1. Introduction {#sec1-ijms-21-04547}
===============

The adenosine A~3~R was the last of the four subtypes to be discovered and was the only subtype that was deorphanized after clone identification \[[@B1-ijms-21-04547]\]. The receptor is expressed in multiple human organs including lung, kidney and brain, and interestingly, A~3~R expression is upregulated in cancers and inflammatory conditions \[[@B2-ijms-21-04547],[@B3-ijms-21-04547],[@B4-ijms-21-04547]\]. As adenosine levels also increase in these conditions/diseases, therapeutic intervention targeting A~3~R offers promising treatment potential \[[@B5-ijms-21-04547]\]. Until recently, because of the "two-fold nature of A~3~R signaling", understanding whether activation of the receptor provided protective or harmful effect was a major challenge for therapeutic development \[[@B1-ijms-21-04547]\]. Currently, clinical trials for treatment of rheumatoid arthritis, plaque psoriasis, non-alcoholic steatohepatitis and hepatocellular carcinoma via agonist targeting of the A~3~ receptors is underway \[[@B6-ijms-21-04547],[@B7-ijms-21-04547],[@B8-ijms-21-04547],[@B9-ijms-21-04547],[@B10-ijms-21-04547]\]. Structure-guided drug discovery will further aid in understanding of the receptor and developing highly selective drugs that minimize adverse events \[[@B6-ijms-21-04547],[@B11-ijms-21-04547]\].

The yeast *S. cerevisiae* is a microbial eukaryotic host uniquely positioned to produce functional GPCRs and to characterize downstream signaling. For example, functional GPCRs have been purified from *S. cerevisiae* \[[@B12-ijms-21-04547],[@B13-ijms-21-04547],[@B14-ijms-21-04547]\] and human GPCRs can signal upon ligand binding via an engineered MAPK response pathway \[[@B15-ijms-21-04547],[@B16-ijms-21-04547],[@B17-ijms-21-04547]\] enabling identification of novel drug candidates \[[@B18-ijms-21-04547]\]. In addition, yeast have been utilized to study GPCR-Gα protein interactions \[[@B19-ijms-21-04547],[@B20-ijms-21-04547]\] and the effect of receptor dimerization on signaling responses \[[@B21-ijms-21-04547]\].

Receptor--receptor chimeras have been utilized to investigate the role of domains in ligand recognition, Gα protein and β-arrestin binding events, and subsequent signaling responses \[[@B22-ijms-21-04547],[@B23-ijms-21-04547]\]. The ligand binding or downstream signaling activity of A~3~R in yeast has been tested previously, but with no measurable activity \[[@B24-ijms-21-04547],[@B25-ijms-21-04547]\]. The adenosine A~2A~ receptor (A~2A~R) shows exceptional expression and trafficking to the plasma membrane in yeast \[[@B14-ijms-21-04547],[@B24-ijms-21-04547]\], unlike its closely related family member A~3~R. In this report, we utilize chimeric receptor protein engineering to produce active A~3~R receptor in yeast. Previously, we have observed improved trafficking to the plasma membrane, and improved yields of native-like active receptor for A~1~R chimeric receptor variants by utilizing the A~2A~R C-terminus \[[@B26-ijms-21-04547]\]. Similarly, by using a human/rat chimeric tachykinin 2 receptor, we observed improved functional levels of the receptor in yeast \[[@B27-ijms-21-04547]\]. Here, we employ a similar strategy to improve the expression and obtain active receptor for A~3~R variants.

2. Results {#sec2-ijms-21-04547}
==========

2.1. Construction of an A~3~/A~2A~R Chimera to Aid in Receptor Expression {#sec2dot1-ijms-21-04547}
-------------------------------------------------------------------------

Recombinant expression of the human A~3~R in yeast has previously resulted in protein that is incapable of binding to its ligand or producing downstream activation \[[@B24-ijms-21-04547],[@B25-ijms-21-04547]\]. On the other hand, the adenosine A~2A~R shows exceptional expression and efficient trafficking to the plasma membrane in yeast \[[@B24-ijms-21-04547]\]. Furthermore, active A~2A~R has been purified from yeast and utilized for resolving a high-resolution crystal structure \[[@B28-ijms-21-04547]\]. Other adenosine receptors A~1~R, A~3~R, and A~2B~R, do not show this proper trafficking in yeast, though they are membrane-integrated \[[@B24-ijms-21-04547]\]. One major difference between A~2A~R and other adenosine receptor subtypes is the remarkably long cytoplasmic carboxy-terminus (C-terminus) of 120 amino acids. We hypothesize that this long A~2A~R C-terminus contains motifs that aid in efficient active receptor expression. Notably, for example, the C-terminus of A~2A~R contains two D/E-X-D/E motifs (located at residues 330 and 382) that would facilitate interaction with the COPII endoplasmic reticulum exit machinery \[[@B29-ijms-21-04547]\], which is absent in A~3~R ([Figure S1](#app1-ijms-21-04547){ref-type="app"}). Previously, a similar A~1~/A~2A~R chimera of A~1~R (1--290) and A~2A~R C-terminus (291--412) showed improved total and functional yields in yeast \[[@B26-ijms-21-04547]\]. Note that both A~1~R and A~2A~R contain an arginine residue at 291. Although A~3~R contains a palmitoylation site at position 303, a similar site is present in A~1~R and was not included in that design, without negative impact. Therefore, to utilize these motifs and any other potential positive interactions from the A~2A~R C-terminus we constructed a chimeric A~3~/A~2A~R containing the N-terminus and transmembrane domains of A~3~R (residues 1--284) and the cytoplasmic A~2A~R C-terminal tail (291--412, [Figure 1](#ijms-21-04547-f001){ref-type="fig"}A,B). It should be noted that the chimeric variant was designed to contain helix 8 of A~2A~R.

The wild-type and chimeric receptor variants were assembled in yeast expression plasmids via homologous recombination ([Figure 1](#ijms-21-04547-f001){ref-type="fig"}C,D). To minimize the effect of plasmid copy number variation on the analysis of receptor expression, a CEN-ARS episomal centromeric plasmid (pRS316) was utilized as a template \[[@B30-ijms-21-04547]\]. The strong, inducible galactose promoter GAL~1--10~ was used to express the receptor variants \[[@B31-ijms-21-04547]\]. A leader peptide was added before the amino-terminus (N-terminus) of each receptor to aid in endoplasmic reticulum targeting of the GPCR \[[@B32-ijms-21-04547]\]. Furthermore, each receptor expression construct contained a C-terminal mCitrine fluorescent protein to facilitate detection of receptor expression and trafficking. As homologous recombination with overlapping sequences was utilized to assemble the receptor variants in the plasmid, no linker was required between the leader peptide and the receptor, and the receptor and the mCitrine fluorescent protein.

2.2. Improved Expression Using the Chimeric A~3~/A~2A~R {#sec2dot2-ijms-21-04547}
-------------------------------------------------------

Yeast cells were transformed with pRS316 vectors containing the A~3~ receptor variants, as described in Materials and Methods. Receptor expression was induced by growing transformed cells in galactose-containing media. No significant changes in growth were observed in recombinant cells expressing either of two receptor variants---wild-type human A~3~R and the A~3~/A~2A~R chimera. Twenty-four hours after galactose induction, cells expressing C-terminal mCitrine-tagged receptor variants were harvested for Western blot analysis ([Figure 2](#ijms-21-04547-f002){ref-type="fig"}A) to determine receptor expression. Lysates of cells expressing the receptor variants showed a prominent band at the expected MW for the full-length receptor, with no significant degradation products observed. Note that A~3~/A~2A~R has a reduced mobility (corresponding to a higher molecular weight of \~55 kDa) than the wild-type A~3~R (MW \~ 45kDa) due to the addition of the longer A~2A~R C-terminus. These data indicate that the cells are capable of producing full-length receptor variants and that the mCitrine fluorescence can serve as an appropriate surrogate for monitoring and optimizing receptor expression and tracking receptor trafficking.

Whole cell mCitrine fluorescence was monitored over time as an indirect measure of total receptor yields. The whole cell fluorescence was monitored for 72 h following galactose induction ([Figure 2](#ijms-21-04547-f002){ref-type="fig"}B). Both the wild-type and chimeric variant showed maximal expression at 18 h post galactose induction, but with different maximal fluorescence levels. The chimeric A~3~/A~2A~R (\~4000 AU) showed approximately two-fold higher maximal mCitrine fluorescence levels than the wild-type receptor (\~2050 AU). This higher fluorescence value suggests improved expression of the chimeric receptor as compared to the wild-type A~3~ receptor. Interestingly, after expression reached its highest value, the chimeric variant showed a slower loss of the chimeric receptor compared with that of the wild-type receptor. The total cellular productivity was determined as the area under the curve from 0 to 72 h. We observed significantly higher productivity for chimeric A~3~/A~2A~R 1.8 × 10^5^ AU (1.6--1.9 × 10^5^ AU, 95% CI) as compared with the wild-type A~3~R 8.0 × 10^4^ AU (7.3--8.8 × 10^4^ AU, 95% CI), representing an over two-fold improvement in total productivity. Taken together, these results for improved and sustained expression of the chimeric variant suggest that the presence of the A~2A~R C-terminus aids in expression of the receptor and may reduce protein turnover.

2.3. Decreased Unfolded Protein Response for the Chimeric A~3~/A~2A~R {#sec2dot3-ijms-21-04547}
---------------------------------------------------------------------

The chaperone Kar2p/BiP binds to nascent secretory and membrane proteins as they enter the endoplasmic reticulum (ER) and aids in proper folding ([Figure S2](#app1-ijms-21-04547){ref-type="app"}). Heterologous protein expression can result in increased cell stress due to the increased protein within the ER, leading to activation of the unfolded protein response (UPR) pathway \[[@B33-ijms-21-04547],[@B34-ijms-21-04547],[@B35-ijms-21-04547]\]. Kar2p/BiP levels are upregulated as part of UPR activation \[[@B33-ijms-21-04547],[@B34-ijms-21-04547],[@B35-ijms-21-04547]\]. We showed previously \[[@B24-ijms-21-04547]\] that cells expressing human A~3~R had an increased UPR as compared with A~2A~R. To investigate the effect of chimeric A~3~/A~2A~R expression on the unfolded stress response, Kar2p/BiP levels were measured in cells expressing the two A~3~ receptor variants via Western blot analysis ([Figure 3](#ijms-21-04547-f003){ref-type="fig"}A). Quantification of Western blot results from four biological replicates showed two-fold lower Kar2p/BiP levels in cells expressing the A~3~/A~2A~R variant as compared to the wild-type A~3~ receptor ([Figure 3](#ijms-21-04547-f003){ref-type="fig"}B). This result suggests that the presence of the A~2A~R C-terminus reduces the UPR stress associated with recombinant receptor expression, possibly contributing to higher receptor expression.

2.4. Increasing Chimeric Receptor Expression by Varying Culture Conditions {#sec2dot4-ijms-21-04547}
--------------------------------------------------------------------------

Changes in the culture conditions can lead to further improvement of receptor expression \[[@B36-ijms-21-04547],[@B37-ijms-21-04547]\]. Previously, we have shown that varying the initial cell density at the time of galactose induction and induction temperature during protein expression had a significant impact on the total receptor yields of "difficult-to-express" receptors like A~1~R \[[@B26-ijms-21-04547]\]. Here, we investigated these conditions for improving total receptor yields of A~3~/A~2A~R. Preliminary data showed mCitrine fluorescence levels for both of the receptor variants were approximately 25% higher when expression was induced at a ten-fold higher initial cell density of 5 OD~600~/mL. We further investigated the impact of lowering the induction temperature from 30 to 15 °C using an initial cell density of 5 OD~600~/mL on receptor expression ([Figure 4](#ijms-21-04547-f004){ref-type="fig"}, dashed lines). Expression of either of the receptors under these conditions resulted in higher mCitrine fluorescence levels, and the chimeric A~3~/A~2A~R showed around 2.4-fold improvement in fluorescent levels as compared with wild-type A~3~R grown at 15 °C at its highest point (\~48 h), and approximately 3.5-fold higher than wild-type A~3~R grown at 30 °C. The total productivity (over the time course) based on total fluorescence was also higher for the chimera---5.2 × 10^5^ AU (4.6--5.9 × 10^5^ AU 95%CI) for the A~3~/A~2A~R as compared with 3.6 × 10^5^ AU (2.7--4.4 × 10^5^ AU, 95% CI) for the wild-type A~3~R. Interestingly, the A~3~/A~2A~R chimera showed a sustained expression at longer times as compared with the wild-type receptor, similar to our observation from induction at 30 °C. Taken together, by utilizing higher initial cell density and lower induction temperature we obtained significantly improved total receptor yields.

2.5. Improved Receptor Trafficking to the Plasma Membrane {#sec2dot5-ijms-21-04547}
---------------------------------------------------------

To investigate whether the reduced UPR and improved A~3~/A~2A~R expression was a result of improved trafficking of the receptor to the plasma membrane that may be correlated with functional receptor, live cell imaging was performed. Receptor localization within the cells was determined by detecting both mCitrine (as a proxy for the C-terminal mCitrine tagged receptor location) and the fluorescent stain calcofluor, which binds to chitin in the cell wall and helps visualize the cell periphery. [Figure 5](#ijms-21-04547-f005){ref-type="fig"}A shows representative confocal micrographs for cells expressing either of the two receptors. Both showed mCitrine fluorescence predominantly inside the cells with some expression localized near the cell periphery. We quantified the results using an in-house tool that quantifies the average Hausdorff distance for individual cells \[[@B38-ijms-21-04547]\]. The average Hausdorff distance between the pixels of mCitrine and Calcofluor stain for all mCitrine pixels was calculated for more than 100 individual cells ([Figure 5](#ijms-21-04547-f005){ref-type="fig"}B). A small number for the Hausdorff distance indicates a minimal distance between the protein and the cell periphery, indicating efficient plasma membrane trafficking of the receptor. Here, we observed Hausdorff distances of 4.7 (4.1--5.4 AU, 95%CI) for A~3~R and of 3.7 AU (3.4--4.0 AU, 95% CI) for A~3~/A~2A~R. The significantly lower Hausdorff distance for chimeric receptor variant suggests improved trafficking of the receptor to the plasma membrane. Previous studies from our laboratory had reported a Hausdorff distance of less than two arbitrary units for membrane-associated, well-trafficked receptors like A~2A~R and the yeast mating receptor (Ste~2~R) \[[@B26-ijms-21-04547]\]. Taken together, this result suggests that the addition of the A~2A~R C-terminus improved receptor trafficking, but that there is still room for further improvement in the plasma membrane trafficking of the receptors.

2.6. Chimeric A~3~/A~2A~ Receptor Was Capable of Downstream Signaling Activity in Yeast {#sec2dot6-ijms-21-04547}
---------------------------------------------------------------------------------------

To test whether the receptor chimeras were capable of producing native-like downstream signaling, engineered yeast strains were utilized. Yeast contains a native GPCR-mediated MAPK pheromone response pathway that has been modified to study the downstream signaling behavior of human receptors \[[@B17-ijms-21-04547],[@B39-ijms-21-04547]\]. To obtain the proper interaction of mammalian GPCRs with the yeast Gα protein (Gpa1p), these cells express a hybrid yeast/human Gα protein. These hybrid Gα proteins contain five amino acid residues from the relevant human Gα protein that enables them to couple with a human GPCR \[[@B17-ijms-21-04547],[@B39-ijms-21-04547]\]. Further modification was performed on these strains to obtain an easily measurable fluorescence-based response as previously described \[[@B40-ijms-21-04547]\]. These modified strains express an mCherry fluorescent protein under control of the Fus1 promoter, which is upregulated upon receptor activation by ligand binding. Therefore, an increase in mCherry fluorescence serves as an downstream reporter of ligand-mediated receptor activation.

Activation of A~3~R in mammalian cells results in a decrease in cyclic adenosine monophosphate (cAMP) levels via its interaction with inhibitory Gαi/o proteins. Consequently, a strain expressing the yeast/human Gαi1 protein (CY13393) was utilized to study the downstream signaling response of the receptors. After 24 h of galactose induction, cells expressing either of the two receptors were stimulated by addition of 100 μM 5′-*N*-ethylcarboxamidoadenosine (NECA), a high affinity non-selective adenosine receptor agonist, and whole cell mCherry fluorescence was measured ([Figure 6](#ijms-21-04547-f006){ref-type="fig"}A). As a control to determine basal activation, cells were exposed to an equivalent volume of DMSO. The A~3~/A~2A~R chimera showed a significant increase in mCherry fluorescence in agonist-treated cells compared to the DMSO control (*p* \< 0.01, Student's *t*-test), while wild-type A~3~R showed no increase in mCherry fluorescence relative to the DMSO control. This result for wild-type receptor is consistent with a previous study that reported that A~3~R was incapable of producing downstream signaling in yeast \[[@B25-ijms-21-04547]\]. The A~3~/A~2A~R chimera activation of downstream signaling suggests that the presence of A~2A~R C-terminus aids trafficking of folded receptor that is competent to bind to the ligand and produce native-like downstream signaling.

2.7. Chimeric Receptor Shows Preferential Coupling with the Inhibitory Gα Protein Family {#sec2dot7-ijms-21-04547}
----------------------------------------------------------------------------------------

To determine whether the chimeric receptor signaling in yeast reflects the G protein binding preferences of the native A~3~ receptor in mammalian cells, we tested the A~3~/A~2A~R chimera activity in a set of 11 yeast strains representing the GPCR-Gα interaction landscape ([Table 1](#ijms-21-04547-t001){ref-type="table"}). The A~3~/A~2A~R chimera showed a ligand-mediated mCherry fluorescence in strains expressing hybrid Gαo, Gαi1 and Gαi3 proteins, i.e., the inhibitory Gα protein subtypes ([Figure 6](#ijms-21-04547-f006){ref-type="fig"}B). Note that the ligand-mediated Gαi1-related response for MMY23 is slightly lower than that reported for the CY13393 ([Figure 6](#ijms-21-04547-f006){ref-type="fig"}A,B), as this set of strains shows overall lower activation, but enables effective comparison of different Gα proteins. We have previously described the specificity of A~2A~R coupling in yeast to Gαs protein, and the promiscuous Gαz, which is consistent with previous reports from Knight et al. \[[@B18-ijms-21-04547]\]. Interestingly, we did not observe increased mCherry fluorescence in cells expressing hybrid Gαs protein, as might be expected if the C-terminus of A~2A~R C-terminus affected the coupling specificity of the chimeric receptor. Taken together, we find that the chimeric A~3~/A~2A~R has native-like downstream coupling preferences for the Gα proteins.

3. Discussion {#sec3-ijms-21-04547}
=============

Obtaining high levels of A~3~R expression has been a major bottleneck for biophysical characterization and high-resolution crystallography. Previously, we utilized chimeric protein engineering of A~1~R in yeast to improve the secretory trafficking and obtained higher active receptor yields. Here, a similar strategy was utilized to improve the expression of surface localized and functional A~3~R. We observed that the A~3~/A~2A~R chimera had improved total receptor yields (approximately 2-fold higher) with reduced UPR stress as compared with wild-type A~3~R expression. The A~3~/A~2A~R chimera showed sustained expression, similar to our previous studies of A~1~/A~2A~R, suggesting the A~2A~R C-terminus may aid in reducing protein turnover \[[@B26-ijms-21-04547]\], by an as yet unknown mechanism. The A~3~/A~2A~R chimera showed improved trafficking to the plasma membrane as compared with the wild-type A~3~ receptor. Surprisingly, both the A~3~/A~2A~R chimera and wild-type A~3~R showed inefficient receptor trafficking to the cell surface, as most of the receptor appeared to be localized inside the cells compared to the well trafficked A~2A~R described previously \[[@B24-ijms-21-04547]\]. This was unexpected as our previous studies of A~1~/A~2A~R and A~2B~/A~2A~R showed improved receptor localization at the plasma membrane \[[@B26-ijms-21-04547],[@B41-ijms-21-04547]\].

Further improvement in total receptor yields was achieved by varying culture conditions such as initial cell density and induction temperature. Receptor expression via the galactose promoter depends on the galactose level in the media. As the cells utilize galactose as a carbon and energy source, galactose is consumed during growth and its level drops over the culture time-course. Therefore, starting with higher initial cell density can result in higher protein yields \[[@B26-ijms-21-04547]\]. Here, we observed a similar increase in total receptor yields when starting at a higher cell density (5 OD~600~/mL as compared to 0.5 OD~600~/mL). Moreover, lowering the induction temperature to 15 °C resulted in a further improvement of total yields, which is consistent with previous reports where similar improvements were observed for membrane proteins including GPCRs \[[@B36-ijms-21-04547],[@B42-ijms-21-04547]\]. Overall, these changes in culture conditions combined with protein engineering resulted in a greater than four-fold higher receptor yield compared with wild-type A~3~R.

Downstream signaling of adenosine receptors A~1~R, A~2A~R and A~2B~R in yeast has been studied extensively \[[@B18-ijms-21-04547],[@B19-ijms-21-04547],[@B43-ijms-21-04547],[@B44-ijms-21-04547],[@B45-ijms-21-04547]\]. To date, the downstream signaling of A~3~R has never been observed in yeast, which has been attributed primarily to inactivity of the recombinantly expressed receptor \[[@B24-ijms-21-04547],[@B25-ijms-21-04547]\]. To the best of our knowledge, this is the first study to report active A~3~R, as observed by downstream signaling activation in the engineered yeast, which provides an exciting opportunity to screen for novel ligands targeting the A~3~R in the microbial yeast system.

4. Materials and Methods {#sec4-ijms-21-04547}
========================

4.1. Cell and Culture Conditions {#sec4dot1-ijms-21-04547}
--------------------------------

*Saccharomyces cerevisiae* strains used in this study are summarized in [Table 1](#ijms-21-04547-t001){ref-type="table"}. BY4741 (*MATa his3*Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0*) was used for protein expression and trafficking experiments. Engineered yeast strains were obtained from Simon Dowell (Glaxo Smith Kline, Stevenage, UK) and the Broach laboratory (Pennsylvania State University) and were further modified to study receptor-mediated downstream signaling \[[@B40-ijms-21-04547]\]. The parental yeast strains were grown in YPD media (2% bacto peptone, 2% glucose, 1% yeast extract). Yeast cells were transformed using lithium chloride \[[@B43-ijms-21-04547]\]. After plasmid transformation, cells were grown in synthetic media (2% dextrose (SD) or galactose (SG), 0.67% yeast nitrogen base, 4.2 g/L citric acid and 14.7 g/L sodium citrate at pH 5.4) supplemented with amino acids and essential nutrients as per Burke et al. \[[@B46-ijms-21-04547]\]. Uracil was omitted from synthetic media (SD-ura or SG-ura) to select for plasmid-containing cells. Individual colonies were selected and grown in culture tubes for expression studies and in 48-well plates (Cat \# 353047, Corning Inc., Corning, NY, USA) for MAPK response experiments. Cells were cultured at 30 or 15 °C, as indicated, at 275 rpm. Cell growth was monitored by measuring optical density at 600 nm (OD~600~) using a Nanodrop 2000 (ThermoFisher Scientific, Waltham, MA, USA). *E. coli* strain DH5α was used for amplifying yeast expression plasmids. *E. coli* were grown in Luria--Bertani media supplemented with 100 μg/mL ampicillin at 37 °C at 250 rpm.

4.2. Plasmid Construction {#sec4dot2-ijms-21-04547}
-------------------------

The A~3~R receptor variants were subcloned into yeast expression plasmids using homologous recombination in yeast \[[@B47-ijms-21-04547]\]. A list of primers utilized for this cloning are described in [Table 2](#ijms-21-04547-t002){ref-type="table"}. The CEN-ARS plasmid (pRS316) \[[@B30-ijms-21-04547]\] containing a galactose (pGAL~1--10~) promoter, a N-terminal pre-pro leader sequence (PP) \[[@B32-ijms-21-04547]\], receptor, and C-terminal mCitrine fluorescent protein and the CYC1 terminator (CYC1~t~) was utilized to express receptor variants for this study and its construction was previously described \[[@B40-ijms-21-04547]\]. The pre-pro leader sequence aids in targeting the receptor to the plasma membrane via the secretory pathway \[[@B32-ijms-21-04547]\]. The PCR-amplified receptor fragments and EagI linearized plasmid were combined at 4:1 molar ratios and transformed into yeast via the lithium chloride transformation protocol \[[@B48-ijms-21-04547]\]. Transformants verified by colony PCR were miniprepped and transformed into *E. coli* using a standard heat shock protocol. All plasmids were sequenced to confirm the correct gene sequence (Genewiz, Plainfield, NJ, USA).

4.3. Whole Cell Fluorescence Assay {#sec4dot3-ijms-21-04547}
----------------------------------

Receptor expression was determined by measuring the fluorescence intensity of mCitrine-tagged receptor. The mCitrine fluorescent intensity was collected at excitation and emission wavelengths of 510 and 540 nm, respectively using a BioTek Synergy H1 microplate reader (Winooski, VT, USA). For mCitrine fluorescence measurements, liquid cultures of cells expressing mCitrine-tagged receptors were removed and transferred to a 96-well plate (100 μL/well) at varying time points. Experiments were performed in triplicate for three independent biological replicates. Mean and standard deviation were reported.

4.4. Western Blotting {#sec4dot4-ijms-21-04547}
---------------------

Western blotting was performed as previously described \[[@B26-ijms-21-04547]\]. Briefly, cell pellets (10 OD~600~) were resuspended in 250 μL lysis buffer (10% glycerol, 50 mM sodium phosphate monobasic and 300 mM sodium chloride at pH 8) supplemented with cOmplete EDTA-free protease inhibitor cocktails (Roche, Indianapolis, IN, USA). An equal volume (250 μL) of 0.5 mm zirconia/silica beads (BioSpec, Bartlesville, OK, USA) was added to the cells and lysed using a BeadBug homogenizer (Benchmark Scientific, Edison, NJ, USA). Cells were lysed for 4 cycles of 30 s with 1-minute rest on ice. Three parts cell lysate was mixed with one part 4X laemmli sample buffer (Biorad, Hercules, CA, USA) supplemented with β-mercaptoethanol. One OD~600~ equivalent of cell lysate was loaded per well. Rabbit polyclonal to Kar2p/BiP was produced and purified from rabbit serum, as per previously published protocol \[[@B49-ijms-21-04547]\]. The mCitrine tagged receptors and Kar2p/BiP protein were detected using primary rabbit anti-GFP antibody (Abcam \#ab6556, Cambridge, MA, USA) and rabbit polyclonal anti-BiP antibody, respectively. Primary antibody was added at 1:3000 dilution in 5% milk dissolved in Tris-buffered saline with Tween20 (20 mM Tris, 150 mM NaCl and 0.1% Tween 20, pH 7.4; TBST) followed by Alexa568 donkey anti-rabbit secondary antibody (Invitrogen, Carlsbad, CA, USA) at 1:3000 dilution in TBST buffer. Blots were imaged using a BioSpectrum imager (UVP, Upland, CA, USA). For quantifying BiP expression levels, experiments were performed in duplicates for three biological replicates. Rectangular selection tool in Image J was used to calculate integrated fluorescent signal intensities for the Kar2p/BiP band on the gels.

4.5. Confocal Microscope {#sec4dot5-ijms-21-04547}
------------------------

Live cells imaging was performed to determine receptor trafficking to the plasma membrane. The C-terminal mCitrine tagged receptors were imaged 24 h after galactose induction using a Nikon A1 laser-scanning confocal microscope. Calcoflour White M2R (Cat \# F3543, Sigma Aldrich, St Louis, MO, USA), a stain that binds to chitin in the yeast cell wall was used to label the cell periphery. Excitation and emission settings of 405 nm and 450/50 nm and 513 nm and 535/15 nm were utilized to image Calcofluor stain and mCitrine fluorescent protein, respectively. Two to four images were collected for each receptor variant from four different biological replicates. Individual cells were cropped and analyzed using an in-house ImageJ plugin. The plugin calculates the average Hausdorff distance between mCitrine and Calcofluor pixels for each mCitrine pixel as previously described \[[@B26-ijms-21-04547],[@B38-ijms-21-04547]\]. The analysis was performed for at least 100 individual cells.

4.6. Pheromone Response Signaling {#sec4dot6-ijms-21-04547}
---------------------------------

The downstream signaling activity of receptors was determined in engineered yeast strains as previously described \[[@B50-ijms-21-04547]\]. Upon ligand-mediated receptor activation, the cells produce mCherry fluorescent protein via a modified MAPK response pathway. Single colonies were picked from freshly made transformants and grown overnight in 400 µL or 1mL SD-ura media in 48-well or 24-well plates (Falcon 353047 and 353078, Corning, NY, USA), respectively, at 30 °C and 275 rpm. Receptor expression was induced by transferring twelve µL of overnight culture into 400 µL SG-ura media supplemented with 0.125% glucose. This small glucose addition aids in cell growth of the engineered yeast strains without repressing the galactose promoter, as previously described \[[@B31-ijms-21-04547],[@B51-ijms-21-04547]\]. After 24 h of galactose induction, ligand was added to activate receptor signaling. In each well of a 48-well plate, 380 µL of fresh SG-ura media, 12 µL of overnight culture, and 8 µL of 5 mM 5′-*N*-ethylcarboxamidoadenosine (NECA, solubilized in dimethyl sulfoxide; Tocris, Minneapolis, MN, USA) or dimethyl sulfoxide (DMSO, added as a control) was added and incubated at 30 °C and 275 rpm. The resulting concentration of NECA in the assay was 100 µM, which is well above the K~D~, but consistent with other yeast studies of adenosine receptor signaling \[[@B39-ijms-21-04547]\]. After 24 h of incubation with ligand, the resulting liquid culture was transferred to three replicate wells (100 µL per well) of a 96-well plate (Costar 3915, Corning, NY, USA). Fluorescence intensity was measured using the BioTek Synergy H1 microplate reader (Winooski, VT, USA) maintained at 30 °C. Excitation and emission settings of 580 nm and 615 nm were used to determine mCherry fluorescence. Experiments were performed at least in biological duplicates from three independent transformants, for a total of six independent colonies.
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![Snake plot for full-length human wild-type A~3~R (**A**) and chimeric A~3~/A~2A~R (**B**), where individual circles represent amino acids. Transmembrane helices are evident in the solid orange-colored representation of the plasma membrane. (**C**) Plasmid map for yeast expression vector pRS316-*GAL~1--10~*-PP-receptor-mCit-cyc~t~. Each receptor construct contains the *GAL~1--10~* promoter \[[@B31-ijms-21-04547]\], an N-terminal leader sequence (PrePro \[[@B32-ijms-21-04547]\], PP) to aid in ER trafficking, and a C-terminal mCitrine fluorescent protein (mCit) to aid in detection of receptor levels. (**D**) Schematic for homologous recombination strategy to generate chimeric A~3~/A~2A~R construct in yeast expression plasmids.](ijms-21-04547-g001){#ijms-21-04547-f001}

![Chimeric A~3~/A~2A~R shows higher total expression levels than A~3~R in BY4741. (**A**) Representative Western blot image for cell lysates of C-terminal mCitrine-tagged receptors expressed in BY4741, 24 h post-galactose induction. One OD~600~ equivalent of whole cell lysates was loaded per well. The protein was detected using an anti-GFP antibody (see [Section 4](#sec4-ijms-21-04547){ref-type="sec"}); Precision Plus Protein WesternC Standard (BioRad, Hercules, CA, USA) was used as a standard to enable molecular weight estimation. Full-length human A~3~ and chimeric A~3~/A~2A~ receptors at expected MW of 45 and 55 kDa, respectively, are identified with arrows. No cleaved mCitrine tag was observed. (**B**) Receptor expression as a function of time, following galactose induction, by monitoring whole cell mCitrine fluorescence (arbitrary units, AU) as a surrogate marker for total receptor levels. Yellow filled circles represent data for A~3~R, whereas black open circles represent A~3~/A~2A~R. Data points are the average of at least 3 biological replicates; lines are a guide for the eye. Error bars represent the standard error from the average. Data points significantly different from A~3~R are indicated with \* (*p*-value \< 0.05 using Student's *t*-test).](ijms-21-04547-g002){#ijms-21-04547-f002}

![BiP/Kar2 expression was reduced in cells expressing the chimeric A~3~/A~2A~R as compared with wild-type A~3~R. (**A**) Representative Western blot of BiP/Kar2 expression levels in recombinant yeast cells. One prominent band (arrow) is observed at the expected MW for BiP/Kar2 of approximately 78 kDa. One OD~600~ equivalent of whole cell lysates were loaded per well. Precision Plus Protein WesternC Standard (BioRad) was used to enable molecular weight estimation. (**B**) Quantification of the average integrated band intensities for BiP/Kar2 levels in A~3~R-expressing cell lines from western blot images, divided by BiP levels on the same western in A~3~/A~2A~R-expressing cells to yield the fold change. Note this normalization results in no error bars for A~3~/A~2A~R data. Experiments were performed for at least four independent biological replicates; error bars represent the 95% confidence interval.](ijms-21-04547-g003){#ijms-21-04547-f003}

![Improving receptor expression by growth at higher initial cell density (5 OD~600~/mL) and induction temperature of 15 °C. Whole cell mCitrine fluorescence was monitored by cells growing in defined media (SG-ura). Yellow-filled circles (30 °C) and squares (15 °C) denote A~3~R, whereas black open squares are A~3~/A~2A~R at 15 °C. Data points represent the average of at least 5 biological replicates; lines are a guide for the eye. Error bars represent the standard error of the mean value. Data points significantly different from A~3~R at 15 °C are indicated with \* (*p*-value \< 0.05 using Student's *t*-test).](ijms-21-04547-g004){#ijms-21-04547-f004}

![Small improvement in trafficking of chimera to the plasma membrane (**A**) Representative live-cell confocal microscopy images showing receptor localization of the mCitrine tagged receptors expressed in BY4741. Calcofluor stain was used to label the cell wall. Scale bar indicates 2 µm. (**B**) Quantification of the average Hausdorff distance for at least a hundred individual cells (points) per receptor. Bars show the mean, with error bars representing the 95% confidence interval. Student's *t*-test was performed to determine significant difference between the two values. \* represents *p*-value \< 0.05.](ijms-21-04547-g005){#ijms-21-04547-f005}

![Chimeric receptor signals downstream in yeast upon ligand binding. (**A**) Chimeric A~3~/A~2A~R receptor signaling in the presence of agonist (100 μM NECA, filled bars) compared with control (DMSO, open bars) is significant, whereas wild-type A~3~R shows no detectable signaling. Both signals were measured in engineered yeast (CY13393) expressing the Gpa1p-human Gαi1 chimera and the indicated receptor. (**B**) A~3~/A~2A~R chimera is activated with native-like coupling to hybrid G~α~i/o proteins. Results obtained for engineered yeast strains with human/yeast G protein chimeras described previously \[[@B17-ijms-21-04547]\]. The average of three independent transformants performed in duplicates is shown; error bars represent the 95% CI. \* represents *p*-value \< 0.05 using Student's *t*-test.](ijms-21-04547-g006){#ijms-21-04547-f006}
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###### 

List of yeast strains used in this study \[[@B15-ijms-21-04547],[@B17-ijms-21-04547]\].

  Yeast Strain     G Protein      Last 5 Amino Acids at C-Terminus   Equivalent Human G~α~
  ---------------- -------------- ---------------------------------- -----------------------------------
  MMY12, BY4741    Gpa1           KIGII^COOH^                        GPA1 (yeast)
  MMY14, CY13397   Gpa1-Gαq(5)    EYNLV^COOH^                        GNAQ, GNA11
  MMY16, CY13395   Gpa1-Gα16(5)   EINLL^COOH^                        GNA15, GNA16
  MMY19            Gpa1-Gα12(5)   DIMLQ^COOH^                        GNA12
  MMY20            Gpa1-Gα13(5)   QLMLQ^COOH^                        GNA13
  MMY21            Gpa1-Gα14(5)   EFNLV^COOH^                        GNA14
  MMY22            Gpa1-Gαo(5)    GCGLY^COOH^                        GNAO
  MMY23, CY13393   Gpa1-Gαi1(5)   DCGLF^COOH^                        GNAI1, GNAI2, GNAT1, GNAT2, GNAT3
  MMY24            Gpa1-Gαi3(5)   ECGLY^COOH^                        GNAI3
  MMY25            Gpa1-Gαz(5)    YIGLC^COOH^                        GNAZ
  MMY28, CY13399   Gpa1-Gαs(5)    QYELL^COOH^                        GNAS, GNAL

ijms-21-04547-t002_Table 2

###### 

List of primers used in this study.

  Primer Name   Sequence                                                       Receptor Variants
  ------------- -------------------------------------------------------------- -----------------------
  PP_A3_F       CGGTTCCGCTGCAGAAGGCTCTTTGGACAAGAGAGAAGCTATGCCCAACAACAGCACTGC   A~3~R and A~3~/A~2A~R
  A3_mCit_R     TTGGGACAACACCAGTGAATAATTCTTCACCTTTAGACATCTCAGAATTCTTCTCAATGC   A~3~R
  A3_A2A_F      CCATGATGAACCCTATCGTCTATGCCTATCGTATCCGCGAGTTCCGCCAGACCTTCCGCA   A~3~/A~2A~R
  A3_A2A_R      TGCGGAAGGTCTGGCGGAACTCGCGGATACGATAGGCATAGACGATAGGGTTCATCATGG   A~3~/A~2A~R
  A2A_mCit_R    TTGGGACAACACCAGTGAATAATTCTTCACCTTTAGACATGGACACTCCTGCTCCATCCT   A~3~/A~2A~R
